Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-19

Clinical Trial Update: Study of Utilization Patterns of Dimethyl Fumarate in Germany

View source ↗

Summary

This completed study investigates how dimethyl fumarate is utilized for multiple sclerosis in Germany.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tecfidera (dimethyl fumarate)

Snippet

Sponsor: Biogen | Conditions: Multiple Sclerosis | Status: COMPLETED